Navigation Links
Avrio Appoints David L. Gelber to Director of Manufacturing
Date:6/29/2010

IRVINE, Calif., June 29 /PRNewswire/ -- Avrio Biopharmaceuticals, LLC, a premier pharmaceutical manufacturing and development organization announces the addition of David A. Gelber as the Director of Manufacturing. Mr. Gelber will be responsible for streamlining and enhancing Avrio's quality production systems and ensuring clients receive high quality service in a timely manner.

"We are excited to have David join Avrio. He is passionate about serving our customers and dedicated to operational excellence," said CEO and Founder, Dr. Assad J. Kazeminy. "David's experience and leadership skills exhibit our commitment to scientific excellence, leading-edge resources, and dependable customer care."

Mr. Gelber has over 25 years of experience with production and project management, and has demonstrated knowledge of all areas of aseptic pharmaceutical manufacturing. David has extensive experience serving as the manufacturing and operations head for both contract and commercial manufacturing operations.  His previous work experience includes serving as the Director of Operations for AAI Development Services, as well as holding a similar sales and management role for B. Braun Medical, Inc.

"David offers our clients solutions to their problems and peace of mind that we'll deliver as promised and we are confident that the future for Avrio is very promising," said Yvonne Verburgt, Vice President of Business Development and Marketing.

To learn more about how Avrio is growing to accommodate client needs, visit www.avriobiopharma.com or call: 866-98-AVRIO.

About Avrio Biopharmaceuticals, LLC

Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, specializing in preformulation/formulation, analytical development, process validation, scale-up studies, packaging and labeling, stability storage and complete analytical CMC testing. Learn more at www.avriobiopharma.com or call 866-98-AVRIO (866-982-8746).


'/>"/>
SOURCE Avrio Biopharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Avrio Receives Drug Manufacturing License and Medical Device Manufacturing License from the California Food and Drug Branch
2. Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing
3. Quark Pharmaceuticals Appoints New Chief Medical Officer
4. West Pharmaceutical Services, Inc. Appoints New Director
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Curemark Appoints Preeminent Pediatrics Gastroenterologist
7. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
10. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
11. NovaRx Appoints Industry Veteran as President and COO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  A new study ... that the use of opioid therapy to treat chronic ... the likelihood of more harmful consequences, including death. ... M.D., and Zankhana Mehta , M.D., authored the ... on chronic opioid therapy. The study was published in ...
(Date:12/8/2016)... CAMBRIDGE, Mass. , Dec. 8, 2016 /PRNewswire/ ... that it has obtained proof-of-mechanism for neflamapimod (previously ... recently completed Phase 2a clinical trials that demonstrated ... from Study 302 (12-week treatment) and Study 303 ... the Clinical Trials in Alzheimer,s Disease (CTAD) scientific ...
(Date:12/8/2016)... 2016 Mederi Therapeutics Inc . hat die behördliche Zulassung ... für gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast ... of Endoscopy at Wuhan Union Hospital ...
Breaking Medicine Technology:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the Affordable Care Act. Dr. Botelho advocates for the mass media launching of ... gives people ongoing opportunities to share their unfortunate experiences; such a movement can ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Jefferson County, is announcing the launch of a ... Birmingham. , The number of homeless women and children in Birmingham has grown ...
(Date:12/8/2016)... ... 08, 2016 , ... Coffey Agencies, a locally owned and ... in the northern Alabama and Georgia regions, is embarking on a charity drive ... has built a network of support and education facilities to develop and provide ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA ... most comprehensive mental health systems reform legislation in more than fifty years. We ... the commitment of our elected officials to improving mental health services and supports ...
(Date:12/7/2016)... LAKE CITY, UTAH (PRWEB) , ... December 07, ... ... productivity, today announced the release of Smart Device Remote Control through a new ... management across all platforms and strengthens its mobile solutions to help businesses maximize ...
Breaking Medicine News(10 mins):